Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Name: Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
License: Public Domain

Tcelltech Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

high-grade glioma, who grade ⅳ glioma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 283027
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.